Myriad Genetics | MYGN - Current Liabilities


Myriad Genetics reported $130.7M in Current Liabilities for its fiscal quarter ending in June of 2026.





Current Liabilities Change Date
Agilent USD 2.29B 20M Jun/2026
Becton, Dickinson and Co. USD 9.4B 897M Jun/2026
Bio-Rad Laboratories USD 961.3M 44.3M Jun/2026
Bruker USD 1.2B 150.4M Jun/2026
Danaher USD 8.1B 645M Jun/2026
Illumina USD 1.58B 12M Jun/2026
J&J USD 54.9B 2.82B Jun/2026
Mettler Toledo International USD 1.2B 92.14M Jun/2026
Myriad Genetics USD 130.7M 500K Jun/2026
OraSure Technologies USD 25.12M 18.96M Jun/2026
Pacific Biosciences Of California USD 68.81M 3.45M Jun/2026
Quest Diagnostics USD 1.79B 389M Jun/2026
Quidel USD 993.4M 31M Jun/2026
Repligen USD 132.66M 6.45M Jun/2026
Revvity USD 1.28B 37.71M Jun/2026
Standard Biotools USD 42.2M 66.1M Mar/2026
Thermo Fisher Scientific USD 15.07B 448M Jun/2026
Veracyte USD 62.74M 6.62M Jun/2026
Waters USD 2.27B 1.03B Mar/2026